Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study

SUMMARY: Romosozumab is an effective treatment for spine osteoporosis because it reduces the incidence of new fractures and significantly increases the percent change in the spine BMD at 12 months. The percent change in the spine BMD is higher in patients not previously treated with other anti-osteo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tominaga, A., Wada, K., Okazaki, K., Nishi, H., Terayama, Y., Kato, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996128/
https://www.ncbi.nlm.nih.gov/pubmed/33770201
http://dx.doi.org/10.1007/s00198-021-05925-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996128/
https://www.ncbi.nlm.nih.gov/pubmed/33770201
http://dx.doi.org/10.1007/s00198-021-05925-3

Ejemplares similares